发布求助
文献互助 智能选刊 最新文献

The Lancet Oncology最新文献

筛选
英文 中文
Cancer drug discovery at warp speed: can AI deliver? 癌症药物研发速度之快：人工智能能否实现？
The Lancet Oncology Pub Date : 2025-07-28 DOI: 10.1016/s1470-2045(25)00431-0
{"title":"Cancer drug discovery at warp speed: can AI deliver?","authors":"","doi":"10.1016/s1470-2045(25)00431-0","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00431-0","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"42 4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144719716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unpublished overall survival confounders in immunomodulatory agent registrational trials – Authors' reply 免疫调节剂注册试验中未发表的总生存混杂因素——作者回复
The Lancet Oncology Pub Date : 2025-07-28 DOI: 10.1016/s1470-2045(25)00417-6
Jesus San-Miguel, Paul Richardson, Meletios A Dimopoulos
{"title":"Unpublished overall survival confounders in immunomodulatory agent registrational trials – Authors' reply","authors":"Jesus San-Miguel, Paul Richardson, Meletios A Dimopoulos","doi":"10.1016/s1470-2045(25)00417-6","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00417-6","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144719717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to Lancet Oncol 2025; 26: 771–80 《柳叶刀-肿瘤》2025年修正；26日:771 - 80
The Lancet Oncology Pub Date : 2025-07-28 DOI: 10.1016/s1470-2045(25)00412-7
{"title":"Correction to Lancet Oncol 2025; 26: 771–80","authors":"","doi":"10.1016/s1470-2045(25)00412-7","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00412-7","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144719586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unpublished overall survival confounders in immunomodulatory agent registrational trials 免疫调节剂注册试验中未发表的总生存混杂因素
The Lancet Oncology Pub Date : 2025-07-28 DOI: 10.1016/s1470-2045(25)00296-7
Jakob Lindberg, Per Sjöberg
{"title":"Unpublished overall survival confounders in immunomodulatory agent registrational trials","authors":"Jakob Lindberg, Per Sjöberg","doi":"10.1016/s1470-2045(25)00296-7","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00296-7","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144719719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurotoxicity-related treatment discontinuations in PRODIGE 51-FFCD-GASTFOX PRODIGE 51-FFCD-GASTFOX的神经毒性相关治疗中断
The Lancet Oncology Pub Date : 2025-07-28 DOI: 10.1016/s1470-2045(25)00341-9
Tuba Uğur Tuzcu, Osman Sütcüoğlu, Orhun Akdoğan, Ozan Yazıcı, Nuriye Özdemir
{"title":"Neurotoxicity-related treatment discontinuations in PRODIGE 51-FFCD-GASTFOX","authors":"Tuba Uğur Tuzcu, Osman Sütcüoğlu, Orhun Akdoğan, Ozan Yazıcı, Nuriye Özdemir","doi":"10.1016/s1470-2045(25)00341-9","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00341-9","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144719720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas 更新RANO工作组和EANO关于胶质瘤PET成像临床应用的建议
The Lancet Oncology Pub Date : 2025-07-28 DOI: 10.1016/s1470-2045(25)00193-7
Norbert Galldiks, Philipp Lohmann, Mariam Aboian, Ramon F Barajas, William G Breen, Jana Ivanidze, Derek R Johnson, Timothy J Kaufmann, Michelle M Kim, Maximilian J Mair, Giuseppe Minniti, Michael Müther, Ali Nabavizadeh, Joshua D Palmer, Roberta Rudà, Marion Smits, Nelleke Tolboom, Sophie E M Veldhuijzen van Zanten, Michael C Veronesi, Jan-Michael Werner, Nathalie L Albert
{"title":"Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas","authors":"Norbert Galldiks, Philipp Lohmann, Mariam Aboian, Ramon F Barajas, William G Breen, Jana Ivanidze, Derek R Johnson, Timothy J Kaufmann, Michelle M Kim, Maximilian J Mair, Giuseppe Minniti, Michael Müther, Ali Nabavizadeh, Joshua D Palmer, Roberta Rudà, Marion Smits, Nelleke Tolboom, Sophie E M Veldhuijzen van Zanten, Michael C Veronesi, Jan-Michael Werner, Nathalie L Albert","doi":"10.1016/s1470-2045(25)00193-7","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00193-7","url":null,"abstract":"This Policy Review provides recommendations for the use of PET imaging in patients with gliomas and represents a joint effort of the Response Assessment in Neuro-Oncology (RANO) working group for PET and the European Association for Neuro-Oncology. The initial guideline was published in 2016, and summarised the previously established clinical benefit of PET with radiolabelled glucose and amino acid tracers in patients with gliomas. Since then, numerous additional studies have been published on this topic, focusing on differential diagnosis, prediction of molecular information, and prognostication. Further studies evaluated PET for biopsy guidance and delineation of glioma extent for local therapy planning, including resection and radiotherapy. In patients undergoing treatment, PET was studied for the assessment of response to local and systemic treatments and PET-based standardised response criteria (PET RANO 1.0) were proposed. In this Policy Review, the updated recommendations are based on evidence generated from studies that validated PET findings by histomolecular findings or clinical course. This guideline further underscores the previously reported clinical value of PET imaging and the superiority of amino acid PET over glucose PET, providing a framework for the use of PET in the management of patients with gliomas. The guideline also underscores the scarcity of class 1 evidence showing that incorporating PET imaging into clinical workflows improves patient outcomes, highlighting priority areas for future clinical studies designed to address this gap.","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"79 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144719725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Access to cancer care for undocumented immigrants in the USA 美国无证移民获得癌症治疗的机会
The Lancet Oncology Pub Date : 2025-07-28 DOI: 10.1016/s1470-2045(25)00207-4
Patricia Mae G Santos, Manisha Dubey, Haley Simpson, Arthur S Hong, Aman Narayan, Sonia Persaud, Katherine Feldman, Emily Anderson, Jennifer Santos, Melina Smith, Monica F Bryant, Joanna F Doran, Mylin A Torres, Lilia Cervantes, K Robin Yabroff, Fumiko Chino
{"title":"Access to cancer care for undocumented immigrants in the USA","authors":"Patricia Mae G Santos, Manisha Dubey, Haley Simpson, Arthur S Hong, Aman Narayan, Sonia Persaud, Katherine Feldman, Emily Anderson, Jennifer Santos, Melina Smith, Monica F Bryant, Joanna F Doran, Mylin A Torres, Lilia Cervantes, K Robin Yabroff, Fumiko Chino","doi":"10.1016/s1470-2045(25)00207-4","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00207-4","url":null,"abstract":"Undocumented immigrants face substantial barriers to affordable health-care coverage in the USA. For people with cancer, federal restrictions on publicly funded health insurance pose serious downstream consequences, including delayed diagnosis, scarce treatment options, and worse health outcomes. In this Policy Review, we examine mechanisms through which undocumented immigrants access cancer care in the USA, focusing on Emergency Medicaid, Medicaid-equivalent plans, and Marketplace-based strategies. We evaluate the strengths and limitations of these approaches, highlighting how each can shape access to cancer prevention, diagnosis, treatment, and follow-up care. We offer insights in regard to the 2025 US presidential administration for states that seek to protect or expand access to cancer care for undocumented immigrants in a challenging sociopolitical climate. The goal of this Policy Review is to guide the creation of innovative policy solutions to mitigate geographical disparities in the hope of improving cancer outcomes for this underserved population.","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"90 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144719724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CRISPR-engineered T-cell therapies: some clarifications needed crispr工程t细胞疗法：需要澄清一些问题
The Lancet Oncology Pub Date : 2025-07-28 DOI: 10.1016/s1470-2045(25)00362-6
Fahreddin Palaz, Sergio Duarte, Ali Zarrinpar
{"title":"CRISPR-engineered T-cell therapies: some clarifications needed","authors":"Fahreddin Palaz, Sergio Duarte, Ali Zarrinpar","doi":"10.1016/s1470-2045(25)00362-6","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00362-6","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144719451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epithelioid sarcoma presenting as a progressively enlarging wound 上皮样肉瘤表现为逐渐扩大的伤口
The Lancet Oncology Pub Date : 2025-07-28 DOI: 10.1016/s1470-2045(25)00378-x
Yu-Ting Tsai, Jui Lan, Yi-Chien Yang
{"title":"Epithelioid sarcoma presenting as a progressively enlarging wound","authors":"Yu-Ting Tsai, Jui Lan, Yi-Chien Yang","doi":"10.1016/s1470-2045(25)00378-x","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00378-x","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Contributors</h2>All authors contributed substantially to the collection of data and drafting of this manuscript, and approved the final version. Written informed consent to publication was obtained.</section></section><section><section><h2>Declaration of interests</h2>We declare no competing interests.</section></section>","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144719726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurotoxicity-related treatment discontinuations in PRODIGE 51-FFCD-GASTFOX – Authors' reply PRODIGE 51-FFCD-GASTFOX的神经毒性相关治疗中断——作者回复
The Lancet Oncology Pub Date : 2025-07-28 DOI: 10.1016/s1470-2045(25)00416-4
Aziz Zaanan, Karine Le Malicot, Julien Taieb
{"title":"Neurotoxicity-related treatment discontinuations in PRODIGE 51-FFCD-GASTFOX – Authors' reply","authors":"Aziz Zaanan, Karine Le Malicot, Julien Taieb","doi":"10.1016/s1470-2045(25)00416-4","DOIUrl":"https://doi.org/10.1016/s1470-2045(25)00416-4","url":null,"abstract":"No Abstract","PeriodicalId":22865,"journal":{"name":"The Lancet Oncology","volume":"131 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144719450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信